Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Trimel Pharmaceutica (TRLPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trimel Pharmaceutica 2486 Dunwin Drive Mississauga A6 L5L 1J9 CAN

P: 416-679-0771

Description:

Acerus Pharmaceuticals Corporation is a pharmaceutical company. The company is focused on the development, manufacture, marketing and distribution of branded products which improve the patient experience. The company's product include ESTRACE(R) which provides symptomatic relief of menopausal symptoms and NATESTO(TM) a bioadhesive intranasal gel formulation of testosterone. It also develops Tefina, an intranasal, low-dose gel formulation of testosterone for women experiencing female orgasmic disorder. Acerus Pharmaceuticals Corp, formerly known as Trimel Pharmaceuticals Corp, is headquartered in Mississauga, Canada.

Key Statistics

Overview:

Market Capitalization, $K 49,542
Shares Outstanding, K 235,240
Annual Sales, $ 6,440 K
Annual Net Income, $ -8,710 K
Last Quarter Sales, $ 2,100 K
Last Quarter Net Income, $ -6,410 K
36-Month Beta 2.69
% of Institutional Shareholders 0.00%

Growth:

1-Year Total Return 147.47%
3-Year Total Return -52.51%
5-Year Total Return -79.96%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 87.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/05/18
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year -200.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

TRLPF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -206.42
Return-on-Assets (Before Tax) -69.23
Net Margin % N/A
Debt/Equity N/A
Price/Sales 7.67
Price/Cash Flow N/A
Price/Book 7.59
Book Value/Share N/A
Interest Coverage -21.82
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar